NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the "Class...
Related Questions
Are there any precedents with similar Nasdaq-listed biotech companies that resulted in significant price corrections or regulatory scrutiny?
How might the securities fraud lawsuit affect LFMD's short-term stock volatility and liquidity?
What potential settlement amounts or legal costs could impact LFMD's financial statements and valuation?